Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma
Author
Segar, Jennifer MPandey, Ritu
Farr, Kiah J
Nagle, Raymond
LeBeau, Lauren
Gonzalez, Victor J
Chalasani, Pavani
Affiliation
Univ Arizona, Ctr CancUniv Arizona, Dept Med
Univ Arizona, Coll Med
Univ Arizona, Dept Pathol
Univ Arizona, Dept Radiat Oncol
Issue Date
2020-11-23
Metadata
Show full item recordPublisher
HINDAWI LTDCitation
Segar, J. M., Pandey, R., Farr, K. J., Nagle, R., LeBeau, L., Gonzalez, V. J., & Chalasani, P. (2020). Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma. International Journal of Breast Cancer, 2020.Rights
Copyright © 2020 Jennifer M. Segar et al. This is an open access article distributed under the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Pleomorphic invasive lobular carcinoma (PILC) is a distinct morphological and biologically aggressive variant of invasive lobular carcinoma (ILC). We hypothesized that was due to de novo activation of PI3K/Akt/mTOR pathway in PILC resulting in higher proliferation rate and markers of cell cycle activation. We identified PILC and ILC tumors and tested for PI3K/Akt/mTOR pathway activation by immunohistochemistry (PTEN and pS6K1) and gene expression analysis (by Nanostring nCounter system). Proliferation index (Ki67) was elevated in 85% of PILCs compared to 20% of ILCs (p < 0.007). PTEN expression was high in all while pS6K1 was high in 8/9 PILCs compared to 3/9 ILCs (p < 0.007). Gene expression analysis shows that PILCs have overexpression of genes involved in cell cycle proliferation, cellular proliferation, DNA damage, and repair genes but no difference in PI3K/Akt/mTOR pathway genes. PILCs are a biologically distinct group of ILC, and clinicopathological characteristics suggest they would have a more clinically aggressive behavior. In addition, our results indicate that PI3k/Akt/mTOR pathway and cell cycle proliferation are activated in majority of these tumors. Further studies are needed to investigate these mechanisms as there are approved therapies available that may benefit PILCs.Note
Open access journalISSN
2090-3170PubMed ID
33299611Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1155/2020/8816824
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2020 Jennifer M. Segar et al. This is an open access article distributed under the Creative Commons Attribution License.
Related articles
- Are the imaging features of the pleomorphic variant of invasive lobular carcinoma different from classic ILC of the breast?
- Authors: Jung HN, Shin JH, Han BK, Ko EY, Cho EY
- Issue date: 2013 Jun
- Seven-year survey of classical and pleomorphic invasive lobular breast carcinomas in women from southeastern Serbia: Differences in clinicopathological and immunohistochemical features.
- Authors: Ilic IR, Djordjevic NP, Randjelovic PJ, Stojanovic NM, Radulovic NS, Ilic RS
- Issue date: 2016 Sept-Oct
- A comparison of the imaging features of pleomorphic and classical invasive lobular carcinoma.
- Authors: Yeap PM, Evans A, Purdie CA, Jordan LB, Vinnicombe SJ
- Issue date: 2018 Nov
- Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
- Authors: Zhu H, Liu Q, Tang J, Xie Y, Xu X, Huang R, Zhang Y, Jin K, Sun B
- Issue date: 2017
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.
- Authors: Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, Zhang LJ
- Issue date: 2009 Feb